RecruitingNCT06953622
Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale
Sponsor
Peking University Third Hospital
Enrollment
330 participants
Start Date
Jan 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent foramen ovale, and search for the possible influencing factors, construct models that influence prognosis.
Eligibility
Inclusion Criteria3
- Meet the diagnostic criteria for migraine in the International Classification of Headache (ICHD-3);
- Confirmation of patent foramen ovale through transthoracic echocardiography(TTE) or transesophageal echocardiography(TEE)/right heart contrast echocardiography
- Agree to participate in the study and sign the informed consent form.
Exclusion Criteria1
- Can not sign the informed consent form or cooperate with follow-up.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGConservative treatment
Receive no antipaletet drug treatment and surgery
DRUGAntipaletet drug
Use of antipaletet drugs.
PROCEDUREPatent Foramen Ovale Closure
Receive the surgery of Patent Foramen Ovale
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06953622
Related Trials
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
NCT056697031 location
Aerobic Exercise and Its Impact on Sensory, Musculoskeletal, and Psychosocial Aspects in Migraine
NCT067164891 location
BE WELL With Migraine: Brain Education and WELLness With Migraine
NCT059875923 locations
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
NCT066241372 locations
Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
NCT049308871 location